Carmignac Gestion Intercept Pharmaceuticals, Inc. Transaction History

Carmignac Gestion

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$9.99 - $18.71 $851,857 - $1.6 Million	85,271 New	85,271 $1.58 Million
Q3 2017 Nov 13, 2017	SELL	$57.01 - $118.75 $116 Million - $242 Million	-2,035,592 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	2,035,592	2,035,592 $246 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Carmignac Gestion, based on Form 13F filings with the SEC.

Stay updated on Carmignac Gestion with notifications on news.